Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Target Price at $61.20

Shares of Astrana Health, Inc. (NASDAQ:ASTHGet Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $61.20.

Several analysts have recently issued reports on ASTH shares. BTIG Research increased their price objective on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Robert W. Baird increased their price target on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research report on Thursday, August 15th. Truist Financial boosted their price objective on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, Stifel Nicolaus raised their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 1st.

View Our Latest Stock Report on Astrana Health

Hedge Funds Weigh In On Astrana Health

Several hedge funds have recently added to or reduced their stakes in the stock. Granite Bay Wealth Management LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $290,000. Central Pacific Bank Trust Division acquired a new stake in Astrana Health during the 3rd quarter worth $160,000. GAMMA Investing LLC purchased a new stake in Astrana Health in the third quarter valued at $34,000. SG Americas Securities LLC acquired a new position in Astrana Health in the third quarter valued at $680,000. Finally, Handelsbanken Fonder AB purchased a new position in shares of Astrana Health during the third quarter worth about $492,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Stock Down 1.0 %

Shares of NASDAQ:ASTH opened at $58.33 on Thursday. The firm has a market capitalization of $3.27 billion, a PE ratio of 44.19, a price-to-earnings-growth ratio of 2.15 and a beta of 1.21. Astrana Health has a 1 year low of $28.86 and a 1 year high of $61.51. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.84 and a quick ratio of 1.84. The firm’s 50-day moving average is $51.51 and its two-hundred day moving average is $44.95.

Astrana Health (NASDAQ:ASTHGet Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.01. The firm had revenue of $486.30 million for the quarter, compared to the consensus estimate of $440.68 million. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The firm’s revenue for the quarter was up 39.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.28 EPS. Analysts predict that Astrana Health will post 1.33 EPS for the current year.

About Astrana Health

(Get Free Report

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Analyst Recommendations for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.